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A B S T R A C T
This study evaluated a new immunochromato-
graphic assay (SAS Legionella Test) for its
ability to detect Legionella pneumophila sero-
group 1 antigen in urine. Results were com-
pared with those obtained using the Binax
Now urinary antigen test. Sensitivity and spe-
cificity were estimated as 82.9% and 99.0%,
respectively, for the SAS Legionella Test,
and 91.4% and 100%, respectively, for the Binax
Now urinary antigen test. The sensitivity of
both tests increased to 97.1% (p 0.009) and
94.2% (p 0.7), respectively, if the tests were
examined after 1 h.
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Legionnaires’ disease (LD) is a pneumonia caused
by Legionella spp., which are ubiquitous Gram-
negative bacilli found in (man-made) aquatic
reservoirs. Legionella spp. are responsible for
1–5% of cases of community-acquired pneumonia
(CAP) requiring hospital admission [1,2]. Antigen
detection in urine has proved to be a sensitive and
rapid method for detecting L. pneumophila sero-
group 1, and this technique is used widely for the
diagnosis of LD [3]. To date, several commercially
available tests have been evaluated for the detec-
tion of L. pneumophila antigen in urine [4–6]. The
aim of the present study was to evaluate a newly
developed immunochromatographic test (ICT) for
the detection of L. pneumophila serogroup 1 anti-
gen in urine.
The new antigen test was evaluated with frozen
urine samples from a well-described sample of
patients with and without LD. Samples were
collected between 1997 and 2005, and were stored
at )70C until processing was performed. The
study investigated 70 urine samples from 70
patients with LD (cases), defined as a patient
with pneumonia and radiological signs of
infiltration, who also showed laboratory evi-
dence of infection with L. pneumophila. Laborat-
ory evidence included one or more of the
following criteria: isolation of L. pneumophila
from a lower respiratory tract sample (LRT
sample); a positive PCR result on a LRT sample
using a 16S rRNA-based assay [7]; and serocon-
version to positive IgM and ⁄ or IgG against
L. pneumophila using a commercially available
ELISA (Serion ELISA; Institut Virion ⁄ Serion
GmbH, Wu¨rzburg, Germany) with paired acute-
phase and convalescent-phase sera. All LD-posit-
ive samples were negative for pneumococcal
antigen in urine (PAG; Binax NOW, Portland,
ME, USA). The laboratory results for these 70
patients were (n (%) positive): serology 53 ⁄ 57
(93%); isolation of L. pneumophila 7 ⁄ 17 (41%);
and PCR 37 ⁄ 37 (100%).
Urine samples from 99 patients with respira-
tory tract infections other than LD were tested in a
similar manner to determine specificity. These
patients were diagnosed with infections caused
by Streptococcus pneumoniae (n = 60), Haemophilus
influenzae (n = 10), Staphylococcus aureus (n = 4),
Moraxella catarrhalis (n = 3) Acinetobacter bauman-
nii (n = 1), Streptococcus pyogenes (n = 2), Klebsiella
pneumoniae (n = 1), Mycobacterium tuberculosis
(n = 3), Escherichia coli (n = 2) Pneumocystis jiro-
vecii (n = 1), influenza A virus (n = 3), adenovirus
(n = 1), Chlamydia psittaci (n = 3), Mycoplasma
pneumoniae (n = 4) and parainfluenza virus
(n = 1).
The presence of L. pneumophila antigen in urine
samples was investigated using the SAS Legio-
nella Test (SA Scientific, San Antonio, TX, USA),
which is a qualitative ICT test. The sensitivity and
specificity of the test were compared with the
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results obtained with a widely used ICT assay, the
Binax Now urinary antigen test (Binax). All tests
were performed simultaneously and the results
were interpreted according to the manufacturers’
instructions. However, to ensure maximum
sensitivity for the urinary antigen tests [8], all
samples were re-examined after 60 min. Fisher’s
exact test was used to compare categorical data,
with p <0.05 considered to be statistically sig-
nificant.
The results obtained are shown in Table 1.
Sensitivity and specificity were 82.9% (58 ⁄ 70)
and 99.0% (1 ⁄ 99), respectively, after incubation
for 10 min with the SAS Legionella Test,
and 91.4% (64 ⁄ 70) and 100% (0 ⁄ 99), respectively,
after incubation for 15 min with the Binax
Now urinary antigen test. The sensitivities
of the SAS Legionella Test and Binax Now
urinary antigen test increased to 97.1% (68 ⁄ 70)
(p 0.009) and 94.2% (66 ⁄ 70) (p 0.7), respect-
ively, if the tests were re-examined after 50
and 45 min, respectively. Prolongation of the
incubation time did not affect the specificity of
either test.
The characteristics of the first urinary antigen
tests for L. pneumophila were reported during the
late 1970s [9] and numerous reports since then
have described various different techniques,
which together provide evidence confirming the
value of urinary antigen detection for the diag-
nosis of infections caused by L. pneumophila
serogroup 1. The capture antibody used in the
majority of these assays is considered to be
specific for L. pneumophila serogroup 1, and
false-positive urinary antigen assay results are
reported rarely [10]. The specificity of the assays
in the current evaluation was determined using
single urine specimens collected from 99 patients
with pneumonia or respiratory tract infections of
known aetiology (but not Legionella). One control
patient with proven pneumococcal pneumonia
(S. pneumoniae isolated from blood culture and
pneumococcal antigen-positive) tested postive by
the SAS Legionella Test.
Based on prospective and retrospective studies
using data from isolated cases, moderate-to-high
urinary antigen test sensitivities have been des-
cribed [4,6,11–15]. These variations may be
explained by differences in test and patient
characteristics, the serogroup infecting the
patient, the timing of collection during the
course of the illness, and whether the urine
was concentrated before testing. A major dis-
advantage with these tests is their inability to
reliably detect organisms other than L. pneumo-
phila serogroup 1, and the development of a
genus-wide urinary antigen test would provide
a distinct diagnostic advantage. The Biotest
Legionella Urine Antigen EIA (Biotest, Dreieich,
Germany) is intended to detect legionellae other
than L. pneumophila serogroup 1, but it does so
less reliably than it detects L. pneumophila sero-
group 1 [15]. In the present evaluation, most
LD-positive patients were probably infected with
L. pneumophila serogroup 1, making it difficult to
reach conclusions concerning infections caused
by other serogroups or Legionella spp. Another
limitation was the relatively small group of
patients that was evaluated, as this could influ-
ence both sensitivity and specificity. Despite
these limitations, the study provided data show-
ing that the SAS Legionella Test has a high
degree of sensitivity and specificity, with a
sensitivity that increased significantly after a
prolonged incubation time. Because prolongation
of incubation does not affect the specificity, it is
recommended that an incubation time longer
than that recommended by the manufacturer is
used routinely.
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A B S T R A C T
Legionella longbeachae was cultured from the spu-
tum of a patient suffering from Legionnaires’
disease. Source identification efforts included
analysis of samples of potting soil from the
patient’s garden, and a genotypically indistin-
guishable strain of L. longbeachae was cultured
from this material. Following examination of a
national collection of Legionella isolates, two more
patients with indistinguishable genotypes were
identified. One of these patients had visited a
garden centre in the same municipality in which
the index patient had acquired his potting soil.
The study demonstrated the value of systematic
collection of identification data and patient iso-
lates over a prolonged period.
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Legionnaires’ disease (LD) is a pneumonia caused
by Legionella spp., predominantly (>90%) Legio-
nella pneumophila. Worldwide, the second most
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